Evaluating the Evolving Real‐World Adverse Events of GLP ‐ 1RAs Using FDA Adverse Event Reporting System ( FAERS )

Documenti analoghi

• Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS)
  di: Jiaqi Guo, et al.
  Pubblicazione: (2026)
• Descriptive Analysis of Ranolazine Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Descriptive Analysis of DALTEPARIN Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• DOFETILIDE Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Prazosin Adverse Events: A Descriptive Analysis of the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)